RecruitingNot Applicable

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

United States60 participantsStarted 2026-04-02

Plain-language summary

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female patients aged 18 or older at the time of study informed consent. * Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible. * Patients have access to digital device capable of downloading study app * Patients able to read study documents and able to complete informed consent within the study app Exclusion Criteria: * Failed prior alloHSCT within the past 6 months

What they're measuring

Objective Sleep Measurement

Timeframe: Continuous measurement throughout the study duration (from 2 weeks prior to alloHSCT to 100 days post-alloHSCT)

Trial details

NCT IDNCT06590285

SponsorScripps Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2031-04-01

Contact for this trial

Jake New, MD, PhD

858-784-2701 new.jacob@scrippshealth.org

View on ClinicalTrials.gov More GVHD trials